Skip to content

Conestat alfa

Ruconest (conestat alfa) is a protein pharmaceutical. Conestat alfa was first approved as Ruconest on 2010-10-28. It has been approved in Europe to treat hereditary angioedemas.
Trade Name Ruconest
Common Name Conestat alfa
Indication hereditary angioedemas
Drug Class Enzyme inhibitors
Conestat alfa
Get full access now